NovaBridge Biosciences (NBP) Goodwill (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Goodwill data on file, last reported at $22.4 million in Q2 2023.

• Goodwill for Q2 2023 came in at $22.4 million, down 7.63% year-over-year; the trailing twelve-month figure through Jun 2023 was $22.4 million (down 7.63% YoY), and the FY2022 annual result was $23.6 billion, up 92295.44% from the prior year.
• Goodwill fell to $22.4 million in Q2 2023 per NBP's latest filing, from $22.9 million in the prior quarter.
• Over five years, Goodwill peaked at $25.4 billion in Q4 2021 and troughed at $22.4 million in Q2 2023.
• A 5-year average of $2.8 billion and a median of $23.9 million in 2020 frame the typical range for Goodwill.
• The sharpest annual moves came in 2021 and 2022: Goodwill jumped 103555.76% in 2021, then plunged 99.91% in 2022.
• A 5-year view of Goodwill shows it stood at $23.1 million in 2019, then gained by 6.35% to $24.5 million in 2020, then jumped by 103555.76% to $25.4 billion in 2021, then sank by 99.91% to $22.9 million in 2022, then decreased by 1.92% to $22.4 million in 2023.
• Business Quant data shows NBP's Goodwill at $22.4 million in Q2 2023, $22.9 million in Q4 2022, and $24.3 million in Q2 2022.